MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10157-018-1537-7

Медицинская библиотека · Clinical and experimental nephrology · 2018

Ensuring safe drug administration to pediatric patients with renal dysfunction: a multicenter study.

Harada Ryoko, Ishikura Kenji, Shinozuka Shunsuke, Mikami Naoaki, Hamada Riku, Hataya Hiroshi, Morikawa Yoshihiko, Omori Tae, Takahashi Hirotaka, Hamasaki Yuko, Kaneko Tetsuji, Iijima Kazumoto, Honda Masataka

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

In pediatric patients, due to variations in baseline serum creatinine (Cr) reference values, renal dysfunctions sometimes go unnoticed. In addition, renally excreted drugs need dose adjustment while nephrotoxic drugs should be avoided altogether in patients with impaired renal function. However, most physicians are apparently unaware of these facts and may administer these drugs to vulnerable patients.

METHODS

We administered a questionnaire to all physicians and pharmacists specializing in pediatric medical care at six Tokyo metropolitan government-run hospitals in Japan.

RESULTS

276 (59%) of 470 physicians and pharmacists participated. The rate of correct answers given by physicians who were asked to state the serum Cr reference range for 4-year-olds and 8-year-olds was 83 and 74%, respectively. On the other hand, the rate of correct answers given by pharmacists to the same question was only 27 and 24%, respectively. Only about 50% of physicians were aware that histamine H2-receptor antagonists and oseltamivir are renally excreted or that acyclovir and angiotensin II receptor blocker are nephrotoxic. However, most of the pharmacists recognized that histamine H2-receptor antagonists and oseltamivir are renally excreted drugs.

CONCLUSIONS

For the majority of the investigated drugs, the awareness that we need to reduce dosages for patients with renal dysfunction was insufficient. To ensure safe drug administration, communication between physicians and pharmacists is paramount. There is an urgent need for the creation of a safe drug administration protocol for pediatric patients with renal dysfunction.

Для цитирования: Harada Ryoko, Ishikura Kenji, Shinozuka Shunsuke, Mikami Naoaki, Hamada Riku, Hataya Hiroshi, Morikawa Yoshihiko, Omori Tae, Takahashi Hirotaka, Hamasaki Yuko, Kaneko Tetsuji, Iijima Kazumoto, Honda Masataka. Ensuring safe drug administration to pediatric patients with renal dysfunction: a multicenter study.. Clinical and experimental nephrology. 2018. DOI: 10.1007/s10157-018-1537-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.